Patents Assigned to SimPharma Pte Ltd
  • USE OF DES-ASPARTATE-ANGIOTENSIN I TO TREAT PATIENTS EXHIBITING INFLAMMATORY DISEASES AND THEIR SYMPTOMS
    Publication number: 20200206302
    Abstract: The present disclosure generally relates to the use of des-aspartate-angiotensin I and/or its derivatives in medicine. In particular, the present invention relates to the use of des-aspartate-angiotensin I and/or its derivatives for the treatment and/or prophylaxis of inflammatory diseases or pathologies, for inducing anti-inflammatory actions and/or reducing inflammation, and/or for treatment of inflammation-related conditions.
    Type: Application
    Filed: February 24, 2020
    Publication date: July 2, 2020
    Applicant: SimPharma Pte Ltd
    Inventor: Meng Kwoon SIM
  • Use of des-aspartate-angiotensin I to treat patients exhibiting malignant growth, invasive growth, tumor, tumor metastasis or cancer
    Patent number: 10568926
    Abstract: The present disclosure generally relates to the use of des-aspartate-angiotensin I and/or its derivatives in medicine. In particular, the present disclosure relates to the use of des-aspartate-angiotensin I and/or its derivatives that are its metabolites for the treatment and/or prophylaxis of inflammatory diseases or pathologies, for inducing anti-inflammatory actions and/or reducing inflammation, and/or for treatment of inflammation-related conditions. Specifically, the disclosure relates to the treatment of a malignant growth, an invasive growth, a tumor, a tumor metastasis, a cancer or combinations thereof and to modulate the level or effect of HSP90 or other inflammation-linked molecules in relevant tissue or blood.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: February 25, 2020
    Assignee: SimPharma Pte Ltd
    Inventor: Meng Kwoon Sim
  • USE OF DES-ASPARTATE-ANGIOTENSIN I TO TREAT PATIENTS EXHIBITING MALIGNANT AND INVASIVE GROWTH, TUMOR, TUMOR METASTASIS OR CANCER
    Publication number: 20170274038
    Abstract: The present disclosure generally relates to the use of des-aspartate-angiotensin I and/or its derivatives in medicine. In particular, the present invention relates to the use of des-aspartate-angiotensin I and/or its derivatives for the treatment and/or prophylaxis of inflammatory diseases or pathologies, for inducing anti-inflammatory actions and/or reducing inflammation, and/or for treatment of inflammation-related conditions.
    Type: Application
    Filed: June 5, 2017
    Publication date: September 28, 2017
    Applicant: SimPharma Pte Ltd
    Inventor: Meng Kwoon SIM
  • Use of des-aspartate-angiotensin I in inflammation-related pathologies and diseases
    Patent number: 9669067
    Abstract: The present disclosure generally relates to the use of des-aspartate-angiotensin I and/or its derivatives in medicine. In particular, the present invention relates to the use of des-aspartate-angiotensin I and/or its derivatives for the treatment and/or prophylaxis of inflammatory diseases or pathologies, for inducing anti-inflammatory actions and/or reducing inflammation, and/or for treatment of inflammation-related conditions.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: June 6, 2017
    Assignee: SimPharma Pte Ltd
    Inventor: Meng Kwoon Sim